TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis

Jiaxi Liu, Peng Wang, Liqi Shang, Zhoubo Zhang, Yulong Tian, Xiaowei Chen, Yanan Ma, Haibo Shao